Share on StockTwits
 

Mead Johnson Nutrition (NYSE:MJN) CFO Peter G. Leemputte unloaded 30,704 shares of the company’s stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price of $80.59, for a total value of $2,474,435.36. Following the transaction, the chief financial officer now directly owns 46,333 shares in the company, valued at approximately $3,733,976. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link.

Shares of Mead Johnson Nutrition (NYSE:MJN) opened at 80.96 on Tuesday. Mead Johnson Nutrition has a 52-week low of $66.80 and a 52-week high of $86.87. The stock has a 50-day moving average of $79.8 and a 200-day moving average of $79.6. The company has a market cap of $16.326 billion and a price-to-earnings ratio of 25.38.

Mead Johnson Nutrition (NYSE:MJN) last released its earnings data on Friday, January 31st. The company reported $0.78 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.77 by $0.01. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the prior year, the company posted $0.72 earnings per share. The company’s quarterly revenue was up 8.0% on a year-over-year basis. On average, analysts predict that Mead Johnson Nutrition will post $3.62 earnings per share for the current fiscal year.

Several analysts have recently commented on the stock. Analysts at Deutsche Bank reiterated a “buy” rating on shares of Mead Johnson Nutrition in a research note on Friday. They now have a $92.00 price target on the stock. Separately, analysts at Morgan Stanley raised their price target on shares of Mead Johnson Nutrition to $85.00 in a research note on Wednesday, February 19th. They now have an “equal weight” rating on the stock. Finally, analysts at Wells Fargo & Co. upgraded shares of Mead Johnson Nutrition from a “market perform” rating to an “outperform” rating in a research note on Monday, February 10th. Seven analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus target price of $87.60.

Mead Johnson Nutrition Company (NYSE:MJN) is a global pediatric nutrition company.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.